Nippon Fine Chemical (4362) FY2027 Q1 Earnings Report

Quick View

Executive Summary

The Company delivered a solid set of results, with higher revenue and profits and an improved operating margin, driven by increased revenue from its core functional products and greater efficiency in selling, general and administrative expenses. Revenue was ¥88.9B (¥81.2B in the same period of the previous year, YoY +9.5%), Operating Income was ¥14.4B (¥12.4B, YoY +16.1%), Ordinary Income was ¥16.1B (¥13.9B, YoY +15.4%), and Net Income (profit attributable to the period) was ¥12.6B (¥10.3B, YoY +22.9%), all exceeding the same period of the previous year. The Operating Income margin improved to 16.2% from 15.3% in the same period of the previous year, an improvement of +0.9pt, securing profit growth above the revenue growth rate. Net income benefited from ¥3.0B in extraordinary income from gains on the sale of investment securities, part of which represents a temporary factor.

Factors Affecting Results

【Revenue】Revenue increased by +9.5% year on year to ¥88.9B. By segment, the core functional products business led performance with ¥70.0B (78.8% of total revenue, YoY +9.8%), while environmental and sanitation products generated ¥18.7B (21.1% of total revenue, YoY +7.8%), and other businesses not included in the reported segments generated ¥0.7B (YoY -24.4%).

【Profit and Loss】Operating Income was ¥14.4B (YoY +16.1%), and the Operating Income margin improved to 16.2% from 15.3% in the previous year, an improvement of +0.9pt. The gross margin declined by -0.5pt to 32.4% from 32.97% in the previous year, while the selling, general and administrative expense ratio remained broadly flat at 16.3%. As the increase in revenue absorbed the rise in costs, positive operating leverage was generated. Ordinary Income was ¥16.1B (YoY +15.4%), supported by ¥1.8B in non-operating income, including ¥1.6B in dividend income. The Company recorded ¥3.0B in extraordinary income (gain on the sale of investment securities, a temporary factor) and ¥0.8B in extraordinary losses (including ¥0.3B in loss on disposal of fixed assets and ¥0.1B in impairment losses), resulting in Profit Before Tax of ¥18.2B. Net Income (profit attributable to the period) was ¥12.6B (YoY +22.9%), of which Net Income attributable to owners of the parent was ¥12.4B (YoY +24.4%, EPS ¥57.37). The Company delivered higher revenue and higher profits.

Segment Analysis

Functional products generated revenue of ¥70.0B (78.8% of total revenue, YoY +9.8%) and Operating Income of ¥12.6B (YoY +14.5%), with a profit margin of 18.0% (17.2% in the previous year, +0.7pt). This is the core business, generating 87.6% of consolidated Operating Income. Environmental and sanitation products generated revenue of ¥18.7B (21.1% of total revenue, YoY +7.8%) and Operating Income of ¥1.5B (YoY +27.5%), with a profit margin of 7.9% (6.7% in the previous year, +1.2pt). Although its profit growth rate exceeded that of functional products, its profit margin remains relatively low. Other businesses, including real estate leasing, contracted to revenue of ¥0.7B (YoY -24.4%), while Operating Income rose significantly to ¥0.3B (YoY +33.6%) and the profit margin improved to 45.5% (25.7% in the previous year, +19.8pt); however, the segment remains small. Profit margins differ substantially among segments, and consolidated performance is highly dependent on trends in the functional products business.

Key Financial Metrics

【Profitability】The Operating Income margin improved to 16.2% (15.3% in the previous year, +0.9pt), while the Net Income margin improved to 14.2% (12.6% in the previous year, +1.6pt). The decline in the gross margin to 32.4% (32.97% in the previous year, -0.5pt) was absorbed through improved SG&A efficiency.【Cash Flow Quality】The net effect of ¥3.0B in extraordinary income (gain on the sale of investment securities) and ¥0.8B in extraordinary losses increased Profit Before Tax by approximately ¥2.1B. This represents approximately 12% of Profit Before Tax of ¥18.2B and approximately 17% of Net Income of ¥12.6B, indicating that a portion of final profit depends on non-recurring factors.【Investment Efficiency】ROE was 2.4% (based on Net Income attributable to owners of the parent), while the total asset turnover ratio remained at 0.136x. In the DuPont decomposition, together with financial leverage of 1.26x, the low total asset turnover ratio is a constraint on ROE.【Financial Soundness】The Equity Ratio was 77.8% (78.5% in the previous year, -0.7pt), the current ratio was 301%, the debt-to-equity ratio was 0.26x, and interest coverage was approximately 5,132x, indicating an extremely strong financial base.

Cash Flow Analysis

Cash and deposits were ¥105.4B, down ¥26.6B (-20.1%) from ¥131.96B at the end of the previous fiscal year. Investment in construction in progress is considered the primary pressure factor. Construction in progress stood at ¥67.5B, increasing by ¥34.0B (+101%) from ¥33.6B at the end of the previous fiscal year, indicating that large-scale capital investment is under way. Investment securities were ¥128.9B, down ¥10.1B (-7.2%) from ¥138.9B at the end of the previous fiscal year, consistent with the ¥3.0B gain on the sale of investment securities recorded as extraordinary income. Inventories were ¥37.3B, increasing by ¥2.5B (+7.0%), suggesting the possibility of inventory accumulation ahead of expanding demand. Income taxes payable were ¥4.5B, a substantial decrease from ¥13.0B at the end of the previous fiscal year, indicating that corporate tax payments progressed. Overall, the Company’s cash position suggests that cash outflows from capital investment and tax payments were partially offset by the sale of investment securities.

Earnings Quality

Against Ordinary Income of ¥16.1B, the Company recorded ¥3.0B in extraordinary income (gain on the sale of investment securities) and ¥0.8B in extraordinary losses (including ¥0.3B in loss on disposal of fixed assets and ¥0.1B in impairment losses), resulting in Profit Before Tax of ¥18.2B. The net contribution from extraordinary gains and losses, approximately ¥2.1B, accounted for approximately 12% of Profit Before Tax and approximately 17% of Net Income of ¥12.6B, indicating that a portion of final profit depends on non-recurring factors. Non-operating income was ¥1.8B, only approximately 2.0% of revenue, and was primarily composed of ¥1.6B in dividend income, a level that cannot be considered excessive dependence. Comprehensive Income was ¥7.7B (¥7.3B attributable to owners of the parent), a difference of more than ¥4B from Net Income of ¥12.6B. The primary factor was other securities valuation difference of -¥6.0B. A portion of unrealized gains declined, compressing Comprehensive Income; therefore, the factors behind movements in this valuation difference should be noted when assessing the quality of earnings for the period.

Earnings Forecast and Guidance

The Q1 progress rates against the Full-Year plan were 23.8% for revenue (¥88.9B against ¥374.0B), 25.2% for Operating Income (¥14.4B against ¥57.0B), 26.8% for Ordinary Income (¥16.1B against ¥60.0B), and 23.9% for Net Income (Net Income attributable to owners of the parent) (¥12.4B against ¥52.0B). Compared with the 25% guideline for evenly distributed quarterly progress, Operating Income and Ordinary Income are slightly ahead, while revenue and Net Income are slightly behind. Overall, results are tracking in line with the plan. No revisions were made to the earnings forecast or dividend forecast during the quarter.

Shareholder Returns

The annual dividend forecast is ¥52, representing an expected increase from the previous fiscal year’s actual dividend of ¥47. Based on the Company’s forecast EPS of ¥239.8, the Payout Ratio is approximately 21.7% (¥52/¥239.8). Given the ample financial base, including an Equity Ratio of 77.8% and a current ratio of 301%, the basis for maintaining dividend payments appears secure. No revisions were made to the dividend forecast as of the end of the quarter.

Risk Factors

1. Segment concentration risk: Functional products account for 78.8% of revenue and 87.6% of segment Operating Income, creating a structure in which demand trends in this segment have a significant impact on consolidated performance.

2. Low capital efficiency: ROE was 2.4% (based on Net Income attributable to owners of the parent), while the total asset turnover ratio remained at 0.136x. The operationalization of construction in progress of ¥67.5B (+101% compared with the end of the previous fiscal year), together with trends in the reduction of working capital such as inventories of ¥37.3B and accounts receivable of ¥80.7B, will be key monitoring points for improving asset efficiency.

3. Dependence on temporary income and securities valuation fluctuations: While ¥3.0B in extraordinary income (gain on the sale of investment securities) boosted Net Income for the period, other securities valuation difference was -¥6.0B, compressing Comprehensive Income. Attention should be paid to the market sensitivity of the ¥128.9B balance of investment securities.

Industry Benchmark (Reference; Compiled by the Company)

Industry Benchmark (manufacturing)

Profitability and Returns

Both the Operating Income margin and Net Income margin substantially exceed the industry median, placing profitability at a high level within the industry.

Growth and Capital Efficiency

The revenue growth rate also exceeds the industry median, indicating a relatively favorable position in both profitability and growth.

※Source: Compiled by the Company

Key Takeaways from the Results

1. The Operating Income margin improved to 16.2% (15.3% in the previous year). With the SG&A expense ratio remaining broadly flat despite higher revenue, positive operating leverage was confirmed.

2. The contribution of extraordinary income, namely the ¥3.0B gain on the sale of investment securities, to Net Income of ¥12.6B was substantial. It is useful to assess this in light of the difference from the core earnings level represented by Ordinary Income of ¥16.1B.

3. Construction in progress accumulated to ¥67.5B, up +101% from the end of the previous fiscal year. Progress in capital investment and its future operationalization may affect the trajectory of the total asset turnover ratio, which currently remains at 0.136x.

Theoretical Share Price (Reference Value)

This is a mechanically calculated reference range based solely on publicly available data using a residual income model (Ohlson-type model with an explicit 5-year fade). It is not a forecast of the market share price or a recommendation of any specific investment action.

Sensitivity: ¥2,406–¥2,549 at ±1% for the cost of equity, and ¥2,474–¥2,479 at ±0.1 for ω.

Notes:

• Net assets as of the end of the quarter are used (there is a timing difference from the Full-Year forecast).
• As net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Model used: Residual Income Model / Interest rate reference month: 2026-06 / This value does not predict or guarantee the future share price)

---

This report is an earnings analysis document automatically generated by AI through analysis of XBRL earnings summary data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting with professionals as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

FY2027 Q1 was a strong operational quarter for Nippon Fine Chemical, with revenue growth, operating-profit outperformance, and higher segment profitability. Revenue rose 9.5% YoY to ¥8.89bn. Operating income increased 16.1% to ¥1.44bn, outpacing sales growth and demonstrating positive operating leverage. The operating margin expanded by 100bp to 16.2% from 15.2% a year earlier, placing profitability above the 15% excellent benchmark. Gross profit rose 7.7% to ¥2.88bn, although the gross margin declined by 52bp to 32.4%, indicating that the operating-margin expansion was primarily driven by SG&A discipline rather than gross-margin improvement. SG&A increased only 0.5% YoY to ¥1.45bn, materially below revenue growth. Ordinary income rose 15.4% to ¥1.61bn, supported by ¥0.16bn of dividend income. Profit attributable to owners climbed 24.4% to ¥1.24bn, and the net margin improved by 170bp to 14.0%. However, reported net income included a ¥0.30bn gain on sale of investment securities, which was a material contributor to the increase in pre-tax income. After adjusting directionally for this pre-tax securities gain, underlying net profit growth appears substantially more moderate than the reported 24.4% increase. Functional Products remained the core business, generating ¥6.96bn of external sales and ¥1.26bn of segment profit. Environmental Hygiene Products delivered faster profit growth than sales, indicating meaningful margin improvement. The company retains a highly conservative balance sheet, with a 301.0% current ratio, 0.26x debt-to-equity ratio, and 77.8% equity ratio. Working-capital intensity remains the principal operating issue, with elevated receivable days, inventory days, and a lengthy cash conversion cycle. Construction in progress has more than doubled YoY and now represents 31.5% of PPE, making execution and eventual returns on the investment pipeline important determinants of future capital efficiency. Full-year guidance is unchanged, and Q1 operating-income progress of 25.2% is broadly in line with the standard 25% seasonal benchmark.

Profitability Analysis

Annualized DuPont ROE is 9.6%, comprising a 14.0% net profit margin, 0.542x asset turnover, and 1.26x financial leverage. The return profile is driven principally by a high margin and conservative balance sheet rather than leverage; financial leverage is low and does not meaningfully amplify shareholder returns. The 9.6% annualized ROE is above the 8% concern threshold but remains below the 10-15% range generally considered good, reflecting modest asset turnover and the sizeable investment-security and fixed-asset base. Operating profit grew 16.1% versus 9.5% revenue growth, as SG&A rose only 0.5%, producing positive operating leverage. Gross margin eased to 32.4% from 33.0% in the prior-year quarter, so the improvement in operating margin was not caused by a better gross-profit mix alone. Functional Products, the core business by operating-income contribution, recorded sales of ¥6.96bn (+9.9% YoY) and segment profit of ¥1.26bn (+14.5%), lifting its segment margin to 18.1% from 17.4%. Environmental Hygiene Products reported sales of ¥1.87bn (+8.0%) and segment profit of ¥0.15bn (+27.5%), with its segment margin improving to 7.9% from 6.7%. Other operations, including real-estate leasing, generated ¥0.06bn of external sales and ¥0.03bn of segment profit. Ordinary income margin improved to 18.1% from 17.1%, assisted by dividend income of ¥0.16bn. The tax burden was 0.685, equivalent to a 30.5% effective tax rate. The interest burden exceeded 1.0x because gains below operating income exceeded finance costs, while interest expense was immaterial. The principal profitability watchpoint is whether the lower gross margin persists once SG&A growth normalizes and construction projects move into operation.

Growth Assessment

Top-line momentum was broad-based across both reportable segments, with Functional Products contributing approximately 91% of reportable-segment sales growth. Functional Products' profit growth exceeded revenue growth, suggesting improved cost absorption and/or favorable product mix. Environmental Hygiene Products produced the stronger incremental margin performance, with segment profit growth of 27.5% on 8.0% sales growth. Consolidated operating income reached 25.2% of the unchanged full-year forecast of ¥5.70bn, essentially in line with the standard Q1 progress rate. Revenue progress was 23.8% of the ¥37.40bn full-year forecast, modestly below the 25% seasonal reference point but not a material deviation. Ordinary-income progress was 26.8% of the ¥6.00bn forecast, partly supported by dividend income. Profit attributable to owners reached 23.9% of the ¥5.20bn forecast; this is near the seasonal benchmark despite the one-time securities-sale gain booked in Q1. Management continues to forecast full-year revenue growth of 10.7%, operating-income growth of 6.7%, and ordinary-income growth of 7.7%. This implies a moderation in operating-profit growth over the remaining quarters relative to Q1's 16.1% pace. The large construction-in-progress balance signals a substantial investment program that could support future capacity, product development, or production modernization, but raises the hurdle for future asset utilization and returns. The Q1 impairment loss of ¥0.08bn in Functional Products is small relative to segment profit and does not alter the segment's current earnings trajectory.

Financial Health

Financial health is robust. Current assets of ¥30.24bn exceeded current liabilities of ¥10.05bn by ¥20.19bn, resulting in a 301.0% current ratio and ¥20.19bn of working capital. The 263.9% quick ratio confirms that liquidity is not dependent on inventory liquidation. Cash and deposits totaled ¥10.54bn, broadly covering current liabilities on their own. Total liabilities were only ¥13.54bn against total equity of ¥52.04bn, producing a conservative 0.26x debt-to-equity ratio and a 77.8% equity ratio. There is no current-ratio or leverage warning: the current ratio is well above 1.0x and D/E is far below 2.0x. Accounts payable of ¥3.54bn and other current liabilities are comfortably covered by liquid current assets, limiting near-term maturity-mismatch risk. Investment securities of ¥12.89bn represented 19.7% of total assets, providing financial asset backing but also exposing comprehensive income and equity to market-value movements. Total equity fell ¥0.35bn YoY despite higher retained earnings, principally reflecting a ¥0.60bn negative valuation difference on securities recognized in OCI during the quarter. Deferred tax liabilities of ¥3.25bn are substantial within non-current liabilities and are consistent with the group's large unrealized valuation gains on securities. Asset-retirement obligations totaled approximately ¥0.59bn, or roughly 0.4% of total liabilities, indicating limited recognized environmental restoration obligations relative to the balance sheet.

Notable B/S Changes

Construction in progress: +¥3.40bn YoY (+101.2%) to ¥6.75bn — now 31.5% of PPE, indicating a substantial investment pipeline and elevating project-execution, timing, and return-on-capital risk. Property, plant and equipment: +¥3.17bn YoY (+17.4%) to ¥21.41bn — fixed-asset expansion should support future operations but requires higher utilization to protect asset turnover. Cash and deposits: -¥2.66bn YoY (-20.1%) to ¥10.54bn — liquidity remains strong, though the decline alongside the expansion in construction in progress highlights capital deployment. Investment securities: -¥1.01bn YoY (-7.2%) to ¥12.89bn — the portfolio remains a substantial 19.7% of total assets and contributed to OCI volatility. Valuation and translation adjustments: -¥0.52bn YoY (-5.5%) to ¥8.94bn — negative market valuation movements in securities reduced equity despite growth in retained earnings.

Cash Flow Quality

Reported earnings quality is affected by the ¥0.30bn gain on sale of investment securities, equal to approximately 24% of profit attributable to owners. This non-recurring gain explains a meaningful portion of the 31.5% increase in profit before tax and makes the 24.4% growth in profit attributable to owners less representative of recurring operating momentum. Ordinary income of ¥1.61bn was stronger than operating income by ¥0.17bn, mainly due to ¥0.16bn of dividend income, which is recurring in form but dependent on the level and payout policies of investee companies. The Q1 extraordinary loss of ¥0.08bn consisted mainly of ¥0.03bn of fixed-asset disposal loss and ¥0.08bn of impairment loss, partly offsetting the securities-sale gain. Working-capital quality requires close monitoring. The quality alert for high receivable days identifies DSO of 83 days, above the 60-day warning threshold; this lengthens the period between sales recognition and cash collection and raises the sensitivity of operating cash generation to customer payment timing. The high inventory-days alert identifies DIO of 142 days, above the 90-day warning threshold; for a chemical manufacturer, this increases carrying-cost, demand-forecasting, product-aging, and potential inventory-valuation risks. The long cash-conversion-cycle alert of 171 days, above the 120-day warning threshold, combines slow collection and inventory intensity into a structurally cash-absorptive operating cycle. These working-capital metrics are particularly important while revenue is growing, because additional sales can require incremental funding before cash is collected. The elevated inventory and receivable cycle also reduces the immediate cash-release benefit of the company's strong accounting profitability. Cash conversion should therefore be assessed through future changes in receivables, inventories, and supplier-credit terms rather than profit growth alone.

Dividend Sustainability

The full-year dividend forecast is ¥104 per share, unchanged from prior guidance. Against forecast EPS of ¥239.80, the implied dividend payout ratio is approximately 43.4%, below the 60% sustainability benchmark. Q1 EPS was ¥57.37, equivalent to 23.9% of full-year forecast EPS, broadly aligned with the earnings progress rate. The conservative balance sheet, substantial retained earnings of ¥328.62bn, and current liquidity support the forecast dividend commitment. The payout assessment should nevertheless emphasize recurring profitability because Q1 reported earnings benefited from a gain on sale of investment securities. No share-buyback amount is reported, so the analysis is limited to the dividend payout ratio rather than a total return ratio. Maintaining dividend growth over time will depend on operating-profit conversion into cash, disciplined execution of the investment pipeline, and preservation of margins in the Functional Products business.

Risk Assessment

Business risks include Working-capital risk: DSO of 83 days exceeds the 60-day warning level. Slow collections can constrain cash conversion as sales expand and may increase exposure to customer-credit or payment-timing issues., Inventory risk: DIO of 142 days exceeds the 90-day warning level. High inventory holdings in chemical manufacturing elevate risks from demand volatility, product obsolescence, storage costs, raw-material price movements, and inventory write-downs., Cash-conversion-cycle risk: the 171-day cash conversion cycle exceeds the 120-day warning level. This indicates a capital-intensive operating cycle and heightens the importance of inventory planning and customer collection discipline., Chemical-industry risk: raw-material and energy-cost volatility, environmental regulation, product quality requirements, and customer qualification cycles can pressure margins and working capital., Investment-security market risk: investment securities account for 19.7% of total assets, and negative securities valuation changes reduced OCI by ¥0.60bn during Q1..

Financial risks include Capital-execution risk: construction in progress rose to ¥6.75bn, up 101.2% YoY, and represents 31.5% of PPE. The quality alert for high CIP indicates elevated risk of project delays, cost overruns, delayed commissioning, or suboptimal returns., Non-recurring earnings risk: the ¥0.30bn securities-sale gain represented approximately 24% of profit attributable to owners, reducing the repeatability of headline net-income growth., Asset-utilization risk: annualized asset turnover of 0.542x is modest, and the expanding fixed-asset base will need to generate additional sales and operating profit to improve capital efficiency., OCI volatility risk: equity is exposed to unrealized securities valuation movements, as evidenced by negative Q1 comprehensive income adjustments despite positive net income..

Key concerns include The four quality alerts—high DSO, high DIO, long cash conversion cycle, and high construction in progress—form a linked risk cluster: cash is tied up in operations while additional capital is committed to projects not yet in service., Gross margin declined by 52bp even as operating margin improved through SG&A restraint; sustained earnings expansion will require stabilization of gross-margin drivers., Full-year guidance assumes a slower operating-profit growth rate after Q1, which warrants monitoring for normalization in margins, demand, or cost conditions..

Investment Implications

Key takeaways include Q1 operating performance was strong: revenue rose 9.5%, operating income rose 16.1%, and operating margin reached 16.2%., Functional Products is the profit engine, contributing ¥1.26bn of ¥1.44bn consolidated operating income and delivering an 18.1% segment margin., Environmental Hygiene Products showed the strongest margin expansion, with segment margin improving by approximately 120bp to 7.9%., Net-income growth was flattered by a ¥0.30bn gain on sale of investment securities; recurring earnings should be judged primarily through operating and ordinary income trends., Liquidity and solvency are strong, but working-capital efficiency and construction-project execution are the main factors affecting cash generation and future returns..

Metrics to watch include Functional Products sales growth and segment margin versus the Q1 18.1% level, Environmental Hygiene Products segment margin versus the Q1 7.9% level, Gross margin versus the Q1 32.4% level, Receivable days, inventory days, and cash conversion cycle versus 83 days, 142 days, and 171 days, respectively, Construction in progress, project commissioning, and resulting PPE utilization, Operating-income progress against the ¥5.70bn full-year forecast, Investment-security valuation movements and their effect on OCI and equity.

Regarding relative positioning, The company combines excellent operating and net margins with a conservative capital structure, differentiating it positively on balance-sheet resilience. Its annualized ROE of 9.6% is solid but not yet in the 10-15% good range because low asset turnover and a sizable financial-asset base limit capital efficiency. Relative performance will be determined by whether high-margin Functional Products growth and the current investment program can lift asset utilization without worsening the already long working-capital cycle.